Articles, guides, and regulatory updates from our community.
A 2026 case report links long-acting growth hormone therapy to severe DKA in a teen without prior diabetes. Learn what the research means for patients.
By Peptide Association Research Team
A 2026 case report links long-acting growth hormone therapy to severe DKA in a child without prior diabetes. Learn what the research suggests for patient safety.
By Peptide Association Research Team
A 2026 case report links long-acting growth hormone therapy to severe DKA in a child without prior diabetes. Learn what clinicians and patients should know.
By Peptide Association Research Team
A 2026 case report reveals a child developed severe DKA after starting long-acting growth hormone therapy. Learn what clinicians and patients should know.
By Peptide Association Research Team
New research explores how DNA methylation and the Wnt signaling pathway may influence Alzheimer's disease progression linked to insulin resistance.
By Peptide Association Research Team
New research explores how mitochondrial dysfunction drives inflammation and beta-cell death in type 2 diabetes—and what emerging therapies may mean for patients.
By Peptide Association Research Team